ExodusPoint Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

ExodusPoint Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-246,417	Closed	-$31.3M	–	1889
2023 Q2	$31.3M	Buy	+246,417	New	+$32M	0.25%	65
2023 Q1	–	Sell	-72,660	Closed	-$9.54M	–	1920
2022 Q4	$9.54M	Buy	+72,660	New	+$9.39M	0.14%	181
2022 Q2	–	Sell	-100,987	Closed	-$13.2M	–	2151
2022 Q1	$13.2M	Buy	+100,987	New	+$13.2M	0.17%	128
2020 Q4	–	Sell	-100,802	Closed	-$13.7M	–	2133
2020 Q3	$13.7M	Buy	100,802 +71,047	+239%	+$9.64M	0.27%	51
2020 Q2	$4.07M	Buy	29,755 +23,955	+413%	+$3.05M	0.11%	204
2020 Q1	$625K	Buy	+5,800	New	+$668K	0.03%	421
2019 Q4	–	Sell	-79,293	Closed	-$7.89M	–	1691
2019 Q3	$7.89M	Buy	79,293 +50,825	+179%	+$5.32M	0.28%	76
2019 Q2	$3.11M	Buy	+28,468	New	+$3.03M	0.12%	114

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ExodusPoint Capital Management's IBB Position: Q3 2023 in Review

ExodusPoint Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 246,417 shares — an estimated $31.3M sold.

ExodusPoint Capital Management first reported a position in IBB in Q2 2019 and held it in 8 quarters. The position peaked at $31.3M in Q2 2023. 832 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

ExodusPoint Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 246,417 iShares Biotechnology ETF shares in Q3 2023, an estimated $31.3M.
ExodusPoint Capital Management first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 8 quarters.
ExodusPoint Capital Management's iShares Biotechnology ETF position peaked at $31.3M in Q2 2023.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.